Rethinking public health campaigns in the COVID-19 era: A call to improve effectiveness, equity and impact

Hamid Jafari; Kristin N. Saarlas; W. William Schluter; Marcos Espinal; Kashef Ijaz; Christopher Gregory; Scott Filler; Chris Wolff; L. Kendall Krause; Katherine O'Brien; Luwei Pearson; Anuradha Gupta; Maria Rebollo Polo; Faisal Shuaib

doi:10.1136/bmjgh-2021-006397

Rethinking public health campaigns in the COVID-19 era: A call to improve effectiveness, equity and impact

Hamid Jafari, Kristin N. Saarlas, W. William Schluter, Marcos Espinal, Kashef Ijaz, Christopher Gregory, Scott Filler, Chris Wolff, L. Kendall Krause, Katherine O'Brien, Luwei Pearson, Anuradha Gupta, Maria Rebollo Polo, Faisal Shuaib

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	e006397
Journal	BMJ Global Health
Volume	6
Issue number	11
DOIs	https://doi.org/10.1136/bmjgh-2021-006397
State	Published - Nov 26 2021

ASJC Scopus subject areas

Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1136/bmjgh-2021-006397

Cite this

Jafari, H., Saarlas, K. N., Schluter, W. W., Espinal, M., Ijaz, K., Gregory, C., Filler, S., Wolff, C., Krause, L. K., O'Brien, K., Pearson, L., Gupta, A., Polo, M. R., & Shuaib, F. (2021). Rethinking public health campaigns in the COVID-19 era: A call to improve effectiveness, equity and impact. BMJ Global Health, 6(11), Article e006397. https://doi.org/10.1136/bmjgh-2021-006397

@article{fb98fb61d303465a8cf60d71993959cb,

title = "Rethinking public health campaigns in the COVID-19 era: A call to improve effectiveness, equity and impact",

author = "Hamid Jafari and Saarlas, {Kristin N.} and Schluter, {W. William} and Marcos Espinal and Kashef Ijaz and Christopher Gregory and Scott Filler and Chris Wolff and Krause, {L. Kendall} and Katherine O'Brien and Luwei Pearson and Anuradha Gupta and Polo, {Maria Rebollo} and Faisal Shuaib",

note = "Funding Information: Historically, health campaign programmes have operated independently from each other, often with limited coordination across programmes and with country health systems. This has resulted in inefficiencies and inequities that can burden healthcare workers and limit the potential impact of these important health interventions. To address this problem, the Health Campaign Effectiveness (HCE) Coalition was formed (the HCE Coalition is funded by a grant from the Bill & Melinda Gates Foundation to the Task Force for Global Health, a 501(c)3 nongovernmental organisation based in Atlanta, Georgia, USA) in early 2020, with the purpose to foster shared learning across different campaign programmes, support countries and partners to undertake implementation research on effective campaign approaches, accelerate the adoption of promising practices and strengthen country capacity to engage with global campaign partners.17 The HCE Coalition brings together country leaders, campaign managers, implementing partners, donors and researchers from across multiple health campaign programmes. Thus far, more than 920 individuals have engaged with the coalition representing NTDs, polio and other vaccine-preventable diseases, malaria and vitamin A supplementation programmes from over 50 countries and 120 organisations. Furthermore, the goals of the coalition are endorsed by key global, regional and national stakeholders including WHO, Pan American Health Organization (PAHO), UNICEF, The Global Fund, Gavi the Vaccine Alliance and the Centers for Disease Control and Prevention (CDC). As members of the coalition{\textquoteright}s Leadership Team, we believe the coalition can serve as a catalyst and a platform for the coordination and integration that WHO and others have called for as a means to strengthen PHC systems while ensuring campaign-based delivery meets population needs. We encourage others to actively participate in the coalition and recommend we collectively work to support the following actions.",

year = "2021",

month = nov,

day = "26",

doi = "10.1136/bmjgh-2021-006397",

language = "English (US)",

volume = "6",

journal = "BMJ Global Health",

issn = "2059-7908",

publisher = "BMJ Publishing Group",

number = "11",

}

TY - JOUR

T1 - Rethinking public health campaigns in the COVID-19 era

T2 - A call to improve effectiveness, equity and impact

AU - Jafari, Hamid

AU - Saarlas, Kristin N.

AU - Schluter, W. William

AU - Espinal, Marcos

AU - Ijaz, Kashef

AU - Gregory, Christopher

AU - Filler, Scott

AU - Wolff, Chris

AU - Krause, L. Kendall

AU - O'Brien, Katherine

AU - Pearson, Luwei

AU - Gupta, Anuradha

AU - Polo, Maria Rebollo

AU - Shuaib, Faisal

N1 - Funding Information: Historically, health campaign programmes have operated independently from each other, often with limited coordination across programmes and with country health systems. This has resulted in inefficiencies and inequities that can burden healthcare workers and limit the potential impact of these important health interventions. To address this problem, the Health Campaign Effectiveness (HCE) Coalition was formed (the HCE Coalition is funded by a grant from the Bill & Melinda Gates Foundation to the Task Force for Global Health, a 501(c)3 nongovernmental organisation based in Atlanta, Georgia, USA) in early 2020, with the purpose to foster shared learning across different campaign programmes, support countries and partners to undertake implementation research on effective campaign approaches, accelerate the adoption of promising practices and strengthen country capacity to engage with global campaign partners.17 The HCE Coalition brings together country leaders, campaign managers, implementing partners, donors and researchers from across multiple health campaign programmes. Thus far, more than 920 individuals have engaged with the coalition representing NTDs, polio and other vaccine-preventable diseases, malaria and vitamin A supplementation programmes from over 50 countries and 120 organisations. Furthermore, the goals of the coalition are endorsed by key global, regional and national stakeholders including WHO, Pan American Health Organization (PAHO), UNICEF, The Global Fund, Gavi the Vaccine Alliance and the Centers for Disease Control and Prevention (CDC). As members of the coalition’s Leadership Team, we believe the coalition can serve as a catalyst and a platform for the coordination and integration that WHO and others have called for as a means to strengthen PHC systems while ensuring campaign-based delivery meets population needs. We encourage others to actively participate in the coalition and recommend we collectively work to support the following actions.

PY - 2021/11/26

Y1 - 2021/11/26

UR - http://www.scopus.com/inward/record.url?scp=85121052826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121052826&partnerID=8YFLogxK

U2 - 10.1136/bmjgh-2021-006397

DO - 10.1136/bmjgh-2021-006397

M3 - Comment/debate

C2 - 34836913

AN - SCOPUS:85121052826

SN - 2059-7908

VL - 6

JO - BMJ Global Health

JF - BMJ Global Health

IS - 11

M1 - e006397

ER -

Rethinking public health campaigns in the COVID-19 era: A call to improve effectiveness, equity and impact

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this